BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38403146)

  • 1. Metabolic profiling in tissues and urine of patients with prostatic lesions and the diagnostic value of urine extracellular vesicles metabolites in prostate cancer.
    Ding T; He W; Yan H; Wei Z; Zeng X; Hao X
    Clin Chim Acta; 2024 Mar; 556():117845. PubMed ID: 38403146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer.
    Park YH; Shin HW; Jung AR; Kwon OS; Choi YJ; Park J; Lee JY
    Sci Rep; 2016 Aug; 6():30386. PubMed ID: 27503267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.
    Puhka M; Takatalo M; Nordberg ME; Valkonen S; Nandania J; Aatonen M; Yliperttula M; Laitinen S; Velagapudi V; Mirtti T; Kallioniemi O; Rannikko A; Siljander PR; Af Hällström TM
    Theranostics; 2017; 7(16):3824-3841. PubMed ID: 29109780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the role of extracellular vesicles as a biomarker under transmission electron microscope in prostate cancer and benign prostate hyperplasia patients.
    Agarwal V; Yadav SS; Kumar S; Mehta N; Talwar G; Qadri J; Sarwar S
    Urologia; 2022 May; 89(2):210-215. PubMed ID: 34024220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry.
    Biggs CN; Siddiqui KM; Al-Zahrani AA; Pardhan S; Brett SI; Guo QQ; Yang J; Wolf P; Power NE; Durfee PN; MacMillan CD; Townson JL; Brinker JC; Fleshner NE; Izawa JI; Chambers AF; Chin JL; Leong HS
    Oncotarget; 2016 Feb; 7(8):8839-49. PubMed ID: 26814433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
    Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
    Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GC-MS-based metabolomics reveals new biomarkers to assist the differentiation of prostate cancer and benign prostatic hyperplasia.
    Wang W; He Z; Kong Y; Liu Z; Gong L
    Clin Chim Acta; 2021 Aug; 519():10-17. PubMed ID: 33831421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies.
    Bernardino RMM; Leão R; Henrique R; Pinheiro LC; Kumar P; Suravajhala P; Beck HC; Carvalho AS; Matthiesen R
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer.
    He J; Han Z; Luo W; Shen J; Xie F; Liao L; Zou G; Luo X; Guo Z; Li Y; Li J; Chen H
    Front Immunol; 2022; 13():998447. PubMed ID: 36685547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer.
    Duijvesz D; Rodriguez-Blanco G; Hoogland AM; Verhoef EI; Dekker LJ; Roobol MJ; van Leenders GJLH; Luider TM; Jenster G
    Prostate; 2019 Jun; 79(9):1032-1042. PubMed ID: 31018022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
    Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.
    Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
    Theranostics; 2020; 10(5):2309-2326. PubMed ID: 32089744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
    Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
    Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis.
    Pang B; Zhu Y; Ni J; Ruan J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
    Int J Nanomedicine; 2020; 15():10241-10256. PubMed ID: 33364756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles.
    Brokāne A; Bajo-Santos C; Zayakin P; Belovs A; Jansons J; Lietuvietis V; Martens-Uzunova ES; Jenster GW; Linē A
    Front Mol Biosci; 2023; 10():1279854. PubMed ID: 38099195
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of the metabolic signatures of prostate cancer by mass spectrometry-based plasma and urine metabolomics analysis.
    Yu C; Niu L; Li L; Li T; Duan L; He Z; Zhao Y; Zou L; Wu X; Luo C
    Prostate; 2021 Dec; 81(16):1320-1328. PubMed ID: 34590739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.
    Royo F; Zuñiga-Garcia P; Torrano V; Loizaga A; Sanchez-Mosquera P; Ugalde-Olano A; González E; Cortazar AR; Palomo L; Fernández-Ruiz S; Lacasa-Viscasillas I; Berdasco M; Sutherland JD; Barrio R; Zabala-Letona A; Martín-Martín N; Arruabarrena-Aristorena A; Valcarcel-Jimenez L; Caro-Maldonado A; Gonzalez-Tampan J; Cachi-Fuentes G; Esteller M; Aransay AM; Unda M; Falcón-Pérez JM; Carracedo A
    Oncotarget; 2016 Feb; 7(6):6835-46. PubMed ID: 26771841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of micro-RNA in extracellular vesicles from blood of patients with prostate cancer.
    Kim J; Cho S; Park Y; Lee J; Park J
    PLoS One; 2021; 16(12):e0262017. PubMed ID: 34972164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.